Digital Strategies in the Pharmaceutical Industry

Front Cover
Springer, Jan 24, 2003 - Business & Economics - 239 pages
0 Reviews
This book is a comprehensive review of the current state of digital innovation, Internet activity and e-business in the life sciences arena and a practical guide for managers planning, developing and implementing e-strategies in the pharmaceutical industry. The authors provide numerous examples of innovative, best practice and lay the strategic foundation for using e-business across the pharmaceutical value chain from drug discovery to physician promotion to direct-to-consumer marketing.

What people are saying - Write a review

We haven't found any reviews in the usual places.


Digital Strategies Research and Development
Digital Strategies Manufacturing Supply Chain and Distribution
Digital Strategies Marketing and Sales
Digital Strategies Health Service Delivery
Managing Digital Strategies
The Future

Other editions - View all

Common terms and phrases

About the author (2003)

LEONARD LERER is currently an adviser to the pharmaceutical and biotechnology industry focusing on investment and analytics. He is also Executive in Residence at the INSEAD Healthcare Management Initiative and was formerly Senior Research Fellow and Affiliate Professor At Large at INSEAD, Fontainebleau, France. He has advised investors, government, pharmaceutical companies, multinational corporations, the World Bank and World Health Organization, and is the founder of a company providing specialized marketing tools to the pharmaceutical industry. He has authored and co-authored more than 70 publications and is regularly an invited speaker at pharmaceutical industry conferences. Leonard Lerer is a medical doctor with post-graduate qualifications in epidemiology, biostatistics and pathology, and an MBA.

MIKE PIPER is a research analyst focusing on the pharmaceuticals and biotechnology sectors. He was formerly a consultant specializing in the life sciences and has worked on a broad range of strategy, due diligence and fundraising projects for clients in the pharmaceutical, biotechnology, medical device, health insurance and publishing industries. In 2001 he co-authored a major report on the future of customer focus and customer value in the pharmaceutical industry with Leonard Lerer. He has a PhD from Cambridge University.

Bibliographic information